Femtosecond laser-assisted cataract surgery compared with phacoemulsification: the FACT non-inferiority RCT
Alexander C Day1,2,3, Jennifer M Burr4, Kate Bennett5
1The National Institute for Health Research (NIHR) Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Health Technology Assessment (Winchester, England)
|January 29, 2021
Summary
Femtosecond laser-assisted cataract surgery (FLACS) demonstrated non-inferior visual acuity compared to traditional phacoemulsification cataract surgery (PCS). FLACS was not found to be cost-effective, with similar safety and patient-reported outcomes observed between the two methods.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Health Economics
Background:
- Cataract surgery is a prevalent surgical procedure.
- Femtosecond laser-assisted cataract surgery (FLACS) offers automation for key surgical steps.
Purpose of the Study:
- To compare the efficacy and safety of FLACS against phacoemulsification cataract surgery (PCS).
- To evaluate visual acuity, refractive outcomes, and patient-reported measures post-surgery.
Main Methods:
- A multicentre, outcome-masked, randomised controlled non-inferiority trial involving 785 patients.
- Patients were randomised to either FLACS (n=392) or PCS (n=393).
- Primary outcome was uncorrected distance visual acuity at 3 months; secondary outcomes included corrected acuity, safety, and patient-reported measures at 3 and 12 months.
Main Results:
- No significant difference in uncorrected or corrected distance visual acuity was found between FLACS and PCS at 3 or 12 months.
- Two posterior capsule tears occurred in the PCS group; no significant differences in safety or patient-reported outcomes were noted.
- While a statistically significant difference favored FLACS in binocular corrected distance visual acuity, it was not deemed clinically significant. FLACS was associated with higher costs and was not cost-effective.
Conclusions:
- FLACS is non-inferior to PCS regarding visual outcomes at 3 months.
- No significant differences in patient-reported health and safety outcomes were observed at 12 months.
- FLACS is not considered cost-effective compared to PCS.
Keywords:
CORRECTED DISTANCE VISUAL ACUITYFEMTOSECOND LASER-ASSISTED CATARACT SURGERYINCREMENTAL COST-EFFECTIVENESS RATIOLAY ADVISORY GROUPLOG OF THE MINIMUM ANGLE OF RESOLUTIONPHACOEMULSIFICATION CATARACT SURGERYQUALITY-ADJUSTED LIFE-YEARUNAIDED DISTANCE VISUAL ACUITY

